Allan Goldstein believes the thymosins he discovered can cure immune diseases, and he hopes his company and institute will prove it WASHINGTON--Science moves too slowly for biochemist Allan Goldstein. For most of his professional life, he has been trying to unravel the mysteries of the human immune system through a better understanding of a group of hormones known as thymosins. He discovered them 26 years ago, and their use in 1974 to save the life of a five-year-old girl, along with his encou
Allan Goldstein believes the thymosins he discovered can cure immune diseases, and he hopes his company and institute will prove it |
Goldstein has been impatient for much of his career, however, with the type of slow, steady progress that his NIH grant would permit. In 1980 the chairman of the biochemistry department of George Washington University in Washington, D.C., took out a $100,000 bank loan and ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
